Literature DB >> 15149623

Implications of the allosteric kinetics of cytochrome P450s.

William M Atkins1.   

Abstract

Drug metabolites can uniquely contribute to therapeutic efficacy, toxicity and drug-drug interactions. Therefore, the rates of formation and clearance of each metabolite are crucially important parameters in the net therapeutic profile of new drugs. However, the recent appreciation for the importance of drug metabolism has made it apparent that the understanding of the fundamental kinetic and biophysical properties of the enzymes that are responsible for catalyzing these reactions, the cytochrome P450s, is incomplete. The need to fully comprehend the complex allosteric behavior of these enzymes has fostered increased scrutiny of cytochrome P450s, which has subsequently resulted in major changes in the way that these enzymes are perceived at the molecular level.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15149623     DOI: 10.1016/S1359-6446(04)03072-7

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  15 in total

1.  Quantifying and predicting the promiscuity and isoform specificity of small-molecule cytochrome P450 inhibitors.

Authors:  Abhinav Nath; Michael A Zientek; Benjamin J Burke; Ying Jiang; William M Atkins
Journal:  Drug Metab Dispos       Date:  2010-09-14       Impact factor: 3.922

2.  Single-molecule fluorescence spectroscopy using phospholipid bilayer nanodiscs.

Authors:  Abhinav Nath; Adam J Trexler; Peter Koo; Andrew D Miranker; William M Atkins; Elizabeth Rhoades
Journal:  Methods Enzymol       Date:  2010       Impact factor: 1.600

Review 3.  Allosteric P450 mechanisms: multiple binding sites, multiple conformers or both?

Authors:  Dmitri R Davydov; James R Halpert
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-12       Impact factor: 4.481

4.  CYP2E1 metabolism of styrene involves allostery.

Authors:  Jessica H Hartman; Gunnar Boysen; Grover P Miller
Journal:  Drug Metab Dispos       Date:  2012-07-17       Impact factor: 3.922

5.  7,8-benzoflavone binding to human cytochrome P450 3A4 reveals complex fluorescence quenching, suggesting binding at multiple protein sites.

Authors:  Glenn A Marsch; Benjamin T Carlson; F Peter Guengerich
Journal:  J Biomol Struct Dyn       Date:  2017-03-20

6.  Mechanism of interactions of alpha-naphthoflavone with cytochrome P450 3A4 explored with an engineered enzyme bearing a fluorescent probe.

Authors:  Tamara N Tsalkova; Nadezhda Y Davydova; James R Halpert; Dmitri R Davydov
Journal:  Biochemistry       Date:  2007-01-09       Impact factor: 3.162

7.  Resolution of multiple substrate binding sites in cytochrome P450 3A4: the stoichiometry of the enzyme-substrate complexes probed by FRET and Job's titration.

Authors:  Harshica Fernando; James R Halpert; Dmitri R Davydov
Journal:  Biochemistry       Date:  2006-04-04       Impact factor: 3.162

8.  The structural basis for homotropic and heterotropic cooperativity of midazolam metabolism by human cytochrome P450 3A4.

Authors:  Arthur G Roberts; Jing Yang; James R Halpert; Sidney D Nelson; Kenneth T Thummel; William M Atkins
Journal:  Biochemistry       Date:  2011-11-22       Impact factor: 3.162

9.  Energetics of heterotropic cooperativity between alpha-naphthoflavone and testosterone binding to CYP3A4.

Authors:  Arthur G Roberts; William M Atkins
Journal:  Arch Biochem Biophys       Date:  2007-04-02       Impact factor: 4.013

10.  Analysis of the cryptophycin P450 epoxidase reveals substrate tolerance and cooperativity.

Authors:  Yousong Ding; Wolfgang H Seufert; Zachary Q Beck; David H Sherman
Journal:  J Am Chem Soc       Date:  2008-03-26       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.